IRIS
PLANTONE, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.365
EU - Europa 3.270
AS - Asia 2.423
SA - Sud America 834
AF - Africa 56
OC - Oceania 7
Totale 9.955
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.298
RU - Federazione Russa 1.048
SG - Singapore 877
BR - Brasile 699
IE - Irlanda 658
CN - Cina 617
IT - Italia 516
HK - Hong Kong 288
SE - Svezia 288
VN - Vietnam 237
FR - Francia 193
GB - Regno Unito 161
KR - Corea 134
ES - Italia 100
DE - Germania 97
FI - Finlandia 65
IN - India 65
AR - Argentina 54
BD - Bangladesh 37
NL - Olanda 33
EC - Ecuador 28
ID - Indonesia 26
CA - Canada 24
IQ - Iraq 23
AT - Austria 21
MX - Messico 21
ZA - Sudafrica 20
TR - Turchia 18
BE - Belgio 15
CL - Cile 15
JP - Giappone 15
SA - Arabia Saudita 15
CZ - Repubblica Ceca 13
PY - Paraguay 11
PK - Pakistan 10
PL - Polonia 10
CO - Colombia 9
UA - Ucraina 9
CH - Svizzera 7
IR - Iran 7
KE - Kenya 7
LT - Lituania 7
VE - Venezuela 7
AU - Australia 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
HU - Ungheria 5
IL - Israele 5
KZ - Kazakistan 5
PE - Perù 5
TT - Trinidad e Tobago 5
AM - Armenia 4
DK - Danimarca 4
MA - Marocco 4
PS - Palestinian Territory 4
PT - Portogallo 4
SN - Senegal 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GE - Georgia 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
NI - Nicaragua 3
RO - Romania 3
RS - Serbia 3
CI - Costa d'Avorio 2
CR - Costa Rica 2
GY - Guiana 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MU - Mauritius 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
QA - Qatar 2
UY - Uruguay 2
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MC - Monaco 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 9.951
Salva come PNG Salva come JPEG
Città #
Dallas 1.013
Dublin 642
Singapore 443
Chandler 378
Santa Clara 324
Moscow 285
Hong Kong 282
Hefei 183
Princeton 165
Beijing 163
Fairfield 143
Seoul 134
Ashburn 122
Milan 88
Southend 88
Ho Chi Minh City 87
Málaga 87
Wilmington 86
Los Angeles 66
São Paulo 60
Siena 50
Hanoi 49
Redondo Beach 46
Helsinki 38
Council Bluffs 37
Seattle 37
Woodbridge 35
San Diego 33
Buffalo 32
Houston 32
Ann Arbor 29
New York 29
Nuremberg 29
Rome 29
Bengaluru 26
Cambridge 26
Florence 23
London 21
Munich 21
Lucca 20
Frankfurt am Main 19
Belo Horizonte 18
Lappeenranta 18
Pisa 17
Brussels 14
Johannesburg 14
Brno 13
Quito 13
Rio de Janeiro 13
Columbus 12
Naples 12
Riyadh 12
Brooklyn 11
Campinas 11
Chicago 11
Goiânia 11
Livorno 11
Messina 11
Shanghai 11
Baghdad 10
San Francisco 10
Toronto 10
Curitiba 9
The Dalles 9
Atlanta 8
Biên Hòa 8
Chennai 8
Haiphong 8
Porto Alegre 8
Turku 8
Bologna 7
Brasília 7
Carlentini 7
Guangzhou 7
Nairobi 7
Norwalk 7
Orem 7
Salvador 7
Sarzana 7
Thái Bình 7
Tokushima 7
Vienna 7
Aracaju 6
City of London 6
Falkenstein 6
Fortaleza 6
Guarulhos 6
Itajaí 6
Jakarta 6
Phoenix 6
Santo André 6
Sorocaba 6
St Petersburg 6
Stockholm 6
Tokyo 6
Uberlândia 6
Warsaw 6
Ankara 5
Brookline 5
Budapest 5
Totale 6.018
Salva come PNG Salva come JPEG
Nome #
An atypical case of Creutzfeldt-Jakob disease mimicking frontotemporal dementia: genotypic influence and clinical implications 442
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 166
Neurofilament light chain and glial fibrillary acid protein levels are elevated in post-mild COVID-19 or asymptomatic SARS-CoV-2 cases 146
B Lymphocytes in Alzheimer's Disease-A Comprehensive Review 141
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 134
Acute Necrotizing Encephalopathy during Novel Influenza A (H1N1) Virus Infection 127
Anorexia Heralding the Onset of Neuromyelitis Optica 124
A Systematic Review Focusing on the Link between Engineered Nanoparticles and Neurodegeneration 123
A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis 122
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 121
Neurological diseases associated with autoantibodies targeting the voltage-gated potassium channel complex: immunobiology and clinical characteristics 118
A Neurometabolic Profile of Secondary Progressive Multiple Sclerosis: The Relationship between Brain Metabolites and Clinical Disability 114
Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders 113
A neurometabolic profile of SPMS: the relationship between brain metabolites and clinical disability 113
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome 112
A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis 112
A case of hemorrhagic Wernicke's encephalopathy following gastric surgery 111
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis 111
Amiloride, Fluoxetine or Riluzole to Reduce Brain Volume Loss in Secondary Progressive Multiple Sclerosis: The MS-SMART Four-Arm RCT 110
Atlantoaxial subluxation in rheumatoid arthritis 110
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis 109
Vitamin D in neurological diseases 107
Acute refractory intestinal pseudo-obstruction in MELAS : Efficacy of prucalopride 105
A longitudinal study of spinal cord atrophy in progressive multiple sclerosis 103
Interferon-beta therapy and risk of thrombocytopenia in multiple sclerosis patients 102
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages 101
Association between Anemia and Multiple Sclerosis 101
Serum growth differentiation factor-15, glial fibrillary acidic protein, and neurofilament light chain: Their link and role in Creutzfeldt-Jakob disease 100
[18F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease 98
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers 97
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer 95
Does Lumbar Puncture Still Have Clinical Value for Patients with Amyotrophic Lateral Sclerosis? 94
CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study 94
Peripherin, a new promising biomarker in neurological disorders 93
CD4(+)T-bet(+), CD4(+)pSTAT3(+) and CD8(+)T-bet(+) T cells accumulate in peripheral blood during NZB treatment 91
Brain perfusion by arterial spin labeling MRI in multiple sclerosis 91
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 88
Retinal nerve fibre layer thickness in the temporal quadrant predicts clinical disability and cervical cord cross sectional area in secondary progressive multiple sclerosis 86
HIV and lower risk of multiple sclerosis: role of adaptive immune response 86
A new national survey of centers for cognitive disorders and dementias in Italy 86
Circulating CD8(+)CD56(-)perforin(+) T cells are increased in multiple sclerosis patients 85
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 84
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 84
The Role of TNF-α in Alzheimer’s Disease: A Narrative Review 83
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 83
CD8+effector and memory T cell subsets in relapsing-onset Multiple Sclerosis 83
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 81
HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence 81
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review 81
Second-line therapy with fingolimod for relapsing-remitting multiple sclerosis in clinical practice: the effect of previous exposure to natalizumab 81
Natural killer lymphocytes in HIV and multiple sclerosis 81
Is There a Role of Vitamin D in Alzheimer's disease? 80
Investigating interleukin-8 in Alzheimer's disease: a comprehensive review 79
Osteoma of the Internal Auditory Canal 79
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study 79
Teaching NeuroImages: A case of hearing loss in a paraneoplastic syndrome associated with anti-Hu antibody 79
Initial cross-sectional MR spectroscopy analysis of a cohort of secondary progressive MS patients enrolled in the MS-SMART trial 79
Tumefactive Demyelinating Lesions and Pregnancy 78
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients 78
Teaching NeuroImages: Basal ganglia involvement in facio-brachial dystonic seizures associated with LGI1 antibodies 78
Optical coherence tomography in secondary progressive multiple sclerosis: a baseline data report from the MS-SMART trial 78
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 78
Midbrain Panda Sign in a Patient with Wilsons Disease 76
Type 1 immune response in progressive multiple sclerosis 76
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview 76
Increased CD4(+)CD25(+)Foxp3(+) T cells in peripheral blood of celiac disease patients: Correlation with dietary treatment 76
Examining cross-sectional relationships of optical coherence tomography, cervical cord MRI and disability in secondary progressive MS 76
Spinal cord area is a stronger predictor of physical disability than brain volume in secondary progressive Multiple Sclerosis 76
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments 75
Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report 75
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 75
Paroxysmal ataxia and dysarthria in multiple sclerosis 75
Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis 75
Brain reserve and physical disability in secondary progressive multiple sclerosis 74
Reply [a: Influenza A (H1N1) in cerebrospinal fluid sample and encephalopathy by Sandoval-Gutiérrez JM, Arcos M, Alva L, Volkow P, T Ferrari T, Quiñones F, Vázquez-Pérez J, Ormsby JE, Hanssen F, Reséndiz A, Alcántara P, Pérez Padilla R, Bautista E] 73
PPIs as possible risk factor for copper deficiency myelopathy 73
Systematic assessment and characterization of chronic pain in multiple sclerosis patients: preliminary results 73
The detection of neural autoantibodies in patients with antiepileptic- drug-resistant epilepsy predicts response to immunotherapy 72
MTR-derived pial and subpial abnormalities in the spinal cord of RRMS patients: a two-year follow-up study 72
Psychological General Well-being, Cognitive Failure, and Inflammation Biomarkers Among Workers 4 Months After a Mild/Asymptomatic SARS-CoV-2 Infection 71
Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis 71
Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations 71
T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity 71
Concurrence of multiple sclerosis and brain tumors 71
Insights into the role of cerebrospinal fluid cytokines in Alzheimer's disease: A commentary on recent findings 70
Neurofilament heavy chain in secondary progressive multiple sclerosis 70
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 70
Riboflavin in Neurological Diseases: A Narrative Review 70
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial 69
Neuroradiological characterization of multiple sclerosis patients with chronic pain 69
Neuroimaging Correlates of Longitudinally Extensive Transverse Myelitis in AQP4-IgG Positive and AQP4-IgG Negative Patients 69
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 68
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet 68
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis 68
Dimethyl fumarate may still have a role in progressive multiple sclerosis 67
Spinal Cord Atrophy in Multiple sclerosis 66
Secondary Progressive Multiple Sclerosis: Definition and Measurement 66
Focal Hyperhidrosis in Tumefactive Multiple Sclerosis 66
Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis 65
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 64
Totale 9.177
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.671
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.132 0 0 290 214 59 22 7 90 43 29 76 302
2022/20231.358 133 129 174 170 81 249 45 82 152 94 24 25
2023/2024840 44 28 35 21 18 223 288 14 5 18 20 126
2024/20252.629 88 148 170 133 279 156 53 143 211 173 256 819
2025/20264.392 488 948 1.053 852 1.021 30 0 0 0 0 0 0
Totale 10.351